SECTIONS
ET APPS
ET TV
LATEST NEWS
- Tamil Nadu reports the highest number of deaths in a single day with 9 people succumbing to Covid-19
- Gautam Navlakha brought to Mumbai, sent in judicial custody
- Rejuvenating Assam's economy: SITA hands over impact assessment studies and action plans to government
- Show strong leadership to tackle COVID-19: Devendra Fadnavis to Maharashtra CM
- Floods: Assam asks Deputy Commissioners to make arrangement as per relief manual, three killed in landslide in Arunachal Pradesh
- India to go ahead with infra development in key areas along LAC notwithstanding stiff resistance by China
- Relentless Bills in US legislatures aimed at unnerving China in an election year
- No major side-effects of HCQ, should be continued as preventive treatment for COVID-19: ICMR
- 67 pc of 92 FPOs' business hit due to COVID-19 lockdown: Survey
Business News›News›ET TV›No major side-effects of Hydroxychloroquine, should be continued as preventive treatment for Covid-19: ICMR
No major side-effects of Hydroxychloroquine, should be continued as preventive treatment for Covid-19: ICMR
No major side-effects of Hydroxychloroquine (HCQ) have been found in studies in India and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday. The ICMR's statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns.
Read more on
Related Videos
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service